Phil Secures $60Million Growth Capital from K2 HealthVentures to Boost AI Integration
July 8, 2025
Phil, a leading software-driven pharmaceutical commercialization platform, announced a $60 million growth debt financing from K2 HealthVentures, a healthcare and life sciences-focused investment firm. The funding will accelerate